Selected Mandates

SILREAL supported AstraZeneca in shaping a comprehensive policy and regulatory strategy for the integration of NCDs into China’s National Public Health Scheme (NPHS).

SILREAL collaborated with the German Federal Government to advance Sino-German collaboration in digital health, driving innovation in telemedicine, AI in healthcare, data integration, and regulatory policy exchange.

Assessment of Nantong as a location for a Saarland innovation hub, covering the healthcare ecosystem, institutional fit, market-entry conditions and execution risks.

SILREAL advised a French private equity firm on investing in Germany’s healthcare products market, with a focus on disposable medical supplies and infection-control products. 

SILREAL supported OPSEO Group, one of Germany’s largest intensive care providers, in the nationwide rollout of a digital duty scheduling and payroll system. Acting as PMO, SILREAL streamlined processes across 20+ subsidiaries and thousands of employees, driving operational efficiency, compliance, and workforce satisfaction.

SILREAL helped Sonova, a leading Swiss hearing aid manufacturer in evaluating the digital brand equity of a potential acquisition target. By combining brand benchmarking, digital performance analysis, and market intelligence, SILREAL provided a transparent, data-driven view of the target’s reputation and market positioning.

SILREAL enabled ESA Grimma, a German mid-sized specialist for electrotechnical solutions, in its international expansion into China’s hospital sector. SILREAL developed a China-specific go-to-market strategy, activated key healthcare networks, and optimized collaboration between headquarters and local representatives.

SILREAL partnered with CordenPharma to optimize pharmaceutical quality systems, streamline documentation workflows, and roll out a global digital compliance platform. By enhancing SOPs, training processes, and audit readiness, SILREAL ensured regulatory adherence and operational excellence across international sites.